Summary
In an attempt to derive diagnostic concepts for thyroid diseases we present pathophysiological models for the prevalent thyroid disorders. ‘Euthyroid goiter’ is a disease mainly caused by iodine deficiency but an additional immunepathogenesis was recently proposed. The ‘immunthyropathy’ is the thyroid disease with orbitopathy and other extraglandular immunological manifestations. A complete model of the immunological phenomena which begin with a tolerance defect is given, and both the T-cell- and B-cell-mediated pathways are detailed. The complex interaction of immunoglobulins at the thyroid-stimulating hormone receptor and their dependency on human leukocyte antigen loci are presented. The peripheral metabolism depends ultimately upon a prevalence of thyroid gland stimulation (thyrotoxicosis) or glandular destruction (hypothyroidism) and this is true for overt thyroid disease under antithyroid drug therapy or any other therapy. Euthyroidism during ‘immunethyropathy’ is presented as an equilibrium between thyroid stimulation and destruction. This concept allows an exact description of the thyroid disease and the resulting clinical situation provided that established laboratory tests are used as suggested by the model. ‘Disseminated thyroid autonomy and autononous thyroid adenoma’ develops during goitrous thyroid disease as a consequence of uncoupling of thyroid cellular growth stimulation, iodine utilization, and thyroid hormone synthesis. The polyclonal origin seems more frequent than monoclonal foci. The size of autononous tissue and individual iodine supply determines the endocrine function in this disease. The TRH test monitors with great sensitivity subtle increases in T4 or T3 production and indicates critical clinical situations earlier than the scintiscan. The exposure of the thyroid gland to large amounts of iodine precipitate thyroid storm and this has lead us to propose a protocol for patients in danger which seems clinically useful. It is hoped that the diagnostic procedures for thyroid diseases are more rational, effective, and less expensive when they are based on modern concepts of pathophysiology.
Similar content being viewed by others
Literatur
Beckers C (1980) Nontoxic Goiter. In: DeVisscher M: The Thyroid Gland. Raven Press, New York, pp 231–256
Bottazzo GF, Pyjol-Borrell R, Hanafusa T, Feldmann M (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet II:1115–1119
Braverman LE (1979) Cell mediated immunity in subacute thyroditis. In: Klein E, Horster FA (eds) Autoimmunity in thyroid diseases. FK Schattauer, Stuttgart New York, pp 79–89
Braverman LE, Ingbar SH, Sterling K (1979) Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest 49:885–864
Buschard K, Madsbad S, Karup T, Rygaard J (1982) Glycaemic control and suppressor cell activity in patients with insulin-dependent diabetes mellitus. Clin Exp Immunol 48:189–195
Carayon P, Adler G, Roulier R, Lissitzky S (1983) Heterogeneity of the Graves' immunoglobulins directed toward the thyrotrophin receptor adenylate cyclase system. J Endocrinol Metab 56:1202
Chopra IJ, Solomon DH, Chopra U, Wu SY, Fisher DA, Nakamira Y (1978) Pathways of metabolism of thyroid hormones. Rec Progr Horm Res 34:521
Chopra IJ (1981) Triiodothyronines in health and disease. Springer, Berlin Heidelberg New York
Coindet JF (1821) Nouvelles recherches sur les effects de l'iode et sur les précautions à suivre dans le traitment des goitres par ce nouveau remède. Ann Chim Phys (Paris) 16:252
Connolly RJ, Vidor GI, Stewart JC (1970) Increase in thryotoxicosis in endemic goitre area after iodation of bread. Lancet I:500
DeVissher M, Ingenbleek Y (1980) Hypothyroidism. In: DeVisscher M: The Thyroid Gland. Raven Press, New York, pp 377–412
Doniach D, Bottazzo GF, Drexhage HA (1982) The autoimmune endocrinopathics. In: Lachmann PJ, Peters K (eds) Clinical Aspects of immunology. Blackwell, Oxford Vol 2, pp 903–937
Doniach D, Bottazzo GF (1983) Autoimmune endocrine disorders. Hospital update, October, pp 1145–1159
Dreher M, Loos U, Pfeiffer EF (1979) T3-production by T4-conversion in lymphocytes isolated from hyperthyroid patients. Acta Endocr (kbh) Suppl 225:abstract 21
Drexhage HA, Bottazo GF, Doniach D, Bitensky L, Chayen J (1980) Evidence for thyroid-growth-stimulating immunglobulins in some goitrous thyroid disease. Lancet II:287
Emrich D (1980) Die medikamentöse Therapie der euthyreoten Struma. Dtsch Med Wschr 105:570–574
Emrich D (1980) Der Einfluß von Jod bei latenten und manifesten hyperthyreoten Zuständen. Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie, Berlin. Referateband, pp 41–52
Ermans AM, Camus M (1972) Modification of thyroid function induced by chronic administration of iodide in the presence of „autonomous“ thyroid tissue. Acta Endocrinol. (Kbh) 70:463–475
Fialkow PW (1976) Clonal origin of human tumors. Biochim Biophys Acta 458:283
Gerber H, Peter HJ, Ramelli F, Miloni E, Koenig MP, Studer H, Berchtold R, Gemsenjäger E (1984) Autonimie und Heterogenität der Follikel in der euthyreoten und hyperthyreoten menschlichen Knotenstruma. Schweiz med Wschr (im Druck)
Grussendorf M, Hüfner M (1977) Induction of T4 to T3 converting enzyme in rat liver by thyroid hormones and analogues. Clin Chim Acta 80:61–66
Hall R (1978) Antigen-Antikörper-Systeme der Schilddrüse. In: Höfer R, Egermann H (eds) Rationale Diagnose von Schilddrüsenerkrankungen. Wien, pp 45–54
Hanafusa T, Chiovato L, Doniach D, Pujol-Borell R, Russel RCG, Bottazzo GF (1983) Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: Relevance for autoimmunity. Lancet II:1111–1115
Hawkins BR, Dawkins RL, Burger HG, Mackay IR, Cheah PS, Whittingham S, Petel Y, Welborn TA (1980) Diagnostic significance of thyroid microsomal antibodies in randomly selected population. Lancet II:1057–1059
Herrmann J, Lehr HJ, Kröll HJ, Musche HJ, Rudorff KH, Krüskemper HL (1975) Exzessive periphere Konversion von T4 zu T3 in der Pathogenese der T3-Hyperthyreose. Dtsch Med Wschr 100:2319–2323
Hesch RD, von zur Mühlen A, Höffken B, Ködding R, Simon R (1978) Diagnose der Hyperthyreose. In: Höfer R (ed) Rationale Diagnose von Schilddrüsenerkrankungen. H Egermann, Wien, pp 131–154
Hesch RD (1981) Die konservative Therapie des extrarenalen Hyperparathyreoidismus. In: Beyer J, Kraue U (eds) Therapie des Hyperparathyroidismus. FK Schattauer, Stuttgart New York, pp 51–69
Hesch RD (1981) The „Low T3-Syndrome“. Academic Press, London New York Toronto Sidney, San Francisco
Hesch RD, LeBlanc S, von zur Mühlen A (1981) Standardisierung des TRH-Testes zur Feineinstellung einer Thyroxin-Behandlung. Dtsch Med Wschr 106:146–149
Hesch RD (1982) Schilddrüsenhormonstoffwechsel und Thyroxin-bindendes Globulin bei Schwerkranken. Akt Endocr Stoffw 3:24–30
Hesch RD, Wagner ThOF (1982) Medikamentöse Therapie von Hypophysentumoren. Dtsch Med Wschr 107:883
Hesch RD (1982) Überlegungen zur medikamentösen Langzeittherapie der Hyperthyreose bei Immunthyreopathie. In: Scriba PC, Rudorff KH, Weinheimer B (eds) Schilddrüse 1981. G Thieme, Stuttgart New York, pp 31–37
Horn K, Gärtner R (1982) TBG- und Thyreoglobulin-Stoffwechsel. Akt Endokr 3:18–23
Islam MN, Pepper BM, Briones-Urbina R, Farid NR (1983) Biological activity of anti thyrotropin anti-idiotypic antibody. Eur J Immunol 13:57–63
Jansson R, Töttermann TH, Sällström J, Dahlberg PA (1983) Thyroid-infiltrating T-Lymphocyte subsets in Hashimoto's thyroiditis. J Clin Endocrinol Metab 56:1164
Klein E, Horster FA (1979) Autoimmunity in thyroid diseases. FK Schattauer, Stuttgart New York
Köbberling J, Hintze G, Dirks H, Emrich D (1980) Spezifische Probleme der Hyperthyreose in höherem Alter. Sektion Schilddrüse der Deutschen Gesellschaft für Endokrinologie, Berlin. Referateband, pp 53–71
Ködding R, Hesch RD (1981) Das „Niedrig-T3-Syndrom“. Intern Welt 6:247
Köhrle J (1982) Physiologische und biochemische Grundlagen des extrathyreoidalen Stoffwechsels von L-Thyroxin und anderen Jodthyroninen. Akt Endokr Stoffw 3:2–12
Köhrle J (1983) Schilddrüsenhormonstoffwechsel — 1983 — Untersuchungen zur Charakterisierung der enzymatischen Dejodierung von L-Thyroxin und anderen Jodthyroninen durch Lebergewebe der Ratte. F Enke, Stuttgart
Kölsch E, Heuer J (1979) Tolerance and autoimmunity — an introductory survey. In: Klein E, Horster FA (eds) Autoimmunity in thyroid disease. FK Schattauer, Stuttgart New York, pp 1–16
Krüskemper HL (1978) Diagnose der Hyperthyreose. In: Höfer R (ed) Rationale Diagnose von Schilddrüsenerkrankungen. H Egermann, Wien, pp 157–167
Larsen PR, Silva JE, Kaplan MM (1981) Relationship between circulating and intracellular thyroid hormones: Physiological and clinical implications. Endocr Rev 2:87–102
Joseph K, Mahlstedt J, Gonnermann R, Herbert K, Welske U (1980) Early recognition and evaluation of the risk of hyperthyroidism in thyroid autonomy in an endemic goitre area. J Rolec Med 4:21
Koutras DA (1980) Clinical aspects of excess iodine in iodine deficiency. J Molec Medic 4:139–149
Krieger DT (1983) Physiopathology of Cushing's disease. Endocr Rev 4:22
Meinhold H (1980) Schilddrüsenhormonmetaboliten. Thieme Copythek, Stuttgart
Melmed S, Braunstein GD, Horvath E, Erzin C, Kovacs K (1983) Pathophysiology of acromegaly. Endocr Rev 3:271–290
Miller JM (1980) Plummer's disease. On overview. M Molec Med 4:3–6
Miloni E, Studer H (1980) Functional and morphologic particularities of the autonomous follicles in human goitres. J Molec Med 4:7
Oppenheimer JH (1982) Evidence of an inhibitor of T4 binding by solid matrices, plasma proteins and cells in patients with non-thyroidal illness. In: Lnager M, Chiandussi L, Chopra IJ, Martini L (eds) The Endocrines and the Liver. Academic Press, London New York, pp 213–216
Pinchera A, Fenzi GF, Bartalena L, Chiovato L, Marcocci L, Pacini F (1979) Thyroid antigens involved in autoimmune thyroid disorders. In: Klein E, Horster FA (eds) Autoimmunity in thyroid diseases. FK Schattauer, Stuttgart New York, pp 49–66
Pinchera A, Fenzi F, Bartalena L, Chiovato L, Marcocci L (1980) Thyroiditis. In: DeVisscher M (ed) The Thyroid Gland. Raven Press, New York, pp 413–442
Plummer HS (1928) The function of the thyroid gland containing adenomatous tissues. Trans Amer Physic 43:159
Pujoll-Borell R, Hanafusa T, Chiovato L, Bottazzo GF (1983) Thyroid cells and their potential to express HLA-DR-antigens. Is it relevant to autoimmunity? Ann D'Endocrinologie 44:71 A (abstract 126)
Reichlin S (1980) Anatomical and physiological basis of the hypothalamuspituitary regulation. In: Post KD, Jackson IMD, Reichlin S (eds) The pituitary adenoma. Plenum, New York, p 3
Rose NR, Kong YM, Okayasu I, Giraldo AA, Busch K, Sundick RS (1981) T-cell regulation in autoimmune thyroiditis. Immunol Rev 55:299–314
Savoie JC, Massing P, Thomopoulos P, Leger F (1975) Iodine-induced thyrotoxicosis in apparently normal thyroid glands. J Clin Endocrinol Metab 41:685–691
Schicha H, Emrich D (1983) Immunogene und nicht immunogene Hyperthyreose. Dtsch Med Wschr 108:6
Schleusener H, Joseph K, Mahlstedt J, Kotulla P, Bogner U, Wenzel B, Meinhold H (1979) Differences between immunogenic toxic diffuse goiter and goiter with dissemninated autonomy: Preliminary results. In: Emrich D, Weinheimer B (eds) Schilddrüse 1979. Elsevier, North Holland, pp 129–133
Schleusener H, Schernthaner G, May WR, Kotulla P, Bogner U, Finke R, Meinhold H, Kopenhagen K, Wenzel KW (1983) HLA-DR3 and HLA-DR5 associated thyrotoxicosis — two different types of toxic diffuse goiter. J Clin Endocrinol Metab 56:781
Schneider C (1983) Arbeitsgemeinschaft Schilddrüse der Deutschen Gesellschaft für Nuklearmedizin. Nuklearmedizin-Informationen 6:14–17
Scriba PC (1978) Prophylaxe, Diagnostik und Therapie der blanden Struma. Med Welt (Stuttg) 29NF.:1075
Scriba PC, Heinze HG, Hesch RD, Reisert PM (1982) Schilddrüse und Peripherie. G Thieme, Stuttgart New York
Smals AGH, Piters GFFM, van Haelst UJG, Kloppenborg PWC (1984) Macronodular adrenocortical hyperplasia in longstanding Cushing's disease. J Clin Endocr Metabl 58:25–31
Sridama V, Pacini F, DeGroot K (1982) Decreased suppressor T-lymphocytes in tuoimmune thyroid diseases detected by monoclonal antibodies. J Clin Endocrinol Metab 54:316
Strakosch CR, Wenzel BE, Row VV, Volpé R (1982) Immunology of autoimmune thyroid disease. New Engl J Med 307:1499
Studer H, Ramelli F (1982) Simple goiter and its variants: Euthyroid and hyperthyroid multinodular goiters. Endocr Rev 3:40
Sung LC, Cavalieri R (1973) T3-thyrotoxicosis due to metastatic thyroid carcinoma. J Clin Endocr 36:215
Svegjard A, Platt P, Ryder LP (1982) HLA and disease-1982. A survey Immunol Res 70:193–218
Teuber J, Helmke K, Mäser E, Grebe S, Federlin K (1981) Nachweis von Schilddrüsenhormonantikörpern sowie ihre Bedeutung für die Klinik. Immunität und Infektion 9:12–19
Valente WA, Vitti P, Rotella M, Vaughan MM, Salvatore MA, Grollman EF, Ambesi-Impionbato FS, Kohn LD (1983) Antibodies that promote thyroid growth. New Engl J Med 309:1028–1034
van den Hove-Vandenbroncke MF (1980) Secretion of thyroid hormones. In: DeVisscher M (ed) Thyroid Gland. Raven Press, New York, p 61–79
van der Heide D, Bolk JH, Bruin TWA, van E LA, Daha MR, Bussemaker JK, Goslings JK, Querido A (1980) Circulating immune complexes and thyroid-stimulating immunoglobulins before, during and after antithyroid drug therapy in patients with Graves' disease. Lancet I:1376–1379
Vidor GI, Stewart JC, Wall JR, Wangel A, Hetzel RS (1973) Pathogenesis of iodineinduced thyrotoxicosis: Studies in northern Tasmania. J Clin Endocrinol Metab 37:901–909
Visser TJ (1980) Thyroid hormone deiodination. Dissertation, Rotterdam
Volpé R, Row VV, Ezrim C (1967) Circulating viral and thyroid antibodies in subactue thyroiditis. J Clin Endocr Metab 27:1257
Volpé R (1978) Die Ätiologie der Schilddrüsenerkrankungen. In: Höfer R (ed) Rationale Diagnose von Schilddrüsenerkrankungen. H Egermann, Wien, pp 9–43
Volpé R (1981) Auto-immunity in thyroid disease. In: Gross FM, Grumbach MM, Labhart M, Lipsett MB, Mann T, Samuels T, Sander J (eds) Monographs of Endocrinology, Vol 20. Springer, Berlin Heidelberg New York, p 19
van Hofe SE, Dorfman SG, Carretta RF, Young RL (1978) The increasing incidence of hypothyroidism within one year after radiorodine therapy for toxic diffuse goiter. J Nucl Med 19:180–148
Weiss M, Ingbar SH, Winblad S, Kasper DL (1983) Demonstration of a saturable binding site for thyrotropin in Yersinia enterocolitica. Science 219:1331
Wick G, Boyd R (1979) Effector mechanism in thyroid autoimmune disease. In: Klein E, Horster FA (eds) Autoimmunity in thyroid disease. FK Schattauer, Stuttgart New York, pp 23–29
Wood LD, Maloof F (1975) Thyroid failure after potassium iodine treatment of diffuse toxic goiter. Trans Ass tumor Phys 88:235
Young RL, Harvey WC, Mazzaferri EL, Reynolds JC, Hamilton CR (1975) Thyroid stimulating hormone level in iodopathic euthyroid goiter. J Clin Endocr 41:21
Zakarija M, McKenzie JM, Banovac K (1980) Clinical significance of assay of thyroid-stimulating antibody in Graves' disease. Ann Intern Med 93:28
Author information
Authors and Affiliations
Additional information
Nach einem Vortrag auf dem Schilddrüsensymposium der Sektion Schilddrüse des Berufsverband Deutscher Internisten, Wiesbaden 1982
Rights and permissions
About this article
Cite this article
Hesch, R.D. Diagnostisches Vorgehen bei Verdacht auf Funktionsstörungen der Schilddrüse. Klin Wochenschr 62, 1059–1073 (1984). https://doi.org/10.1007/BF01711375
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01711375